NASDAQ:PTE - Nasdaq - US7310942070 - Common Stock - Currency: USD
0.241
0 (-0.82%)
The current stock price of PTE is 0.241 USD. In the past month the price decreased by -36.91%. In the past year, price decreased by -85.39%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 19.97 | 357.10B | ||
AMGN | AMGEN INC | 15.29 | 162.72B | ||
GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
NTRA | NATERA INC | N/A | 21.43B | ||
BIIB | BIOGEN INC | 8.54 | 20.49B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The company is headquartered in Salt Lake City, Utah and currently employs 42 full-time employees. Its first regenerative tissue product is SkinTE. Its SkinTE is intended for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The firm's development projects include SkinTE Point-of-Care Device, SkinTE Cryo and Other Tissue Regeneration Products. SkinTE Cryo allows it to offer multiple deployments from one original harvest through a cryopreservation process. The core technology of SkinTE is minimally polarized functional units (MPFUs). MPFUs are multi-cellular segments created from a piece of the patient’s healthy skin.
POLARITYTE INC
1960 S. 4250 West
Salt Lake City UTAH 84116 US
CEO: David Seaburg
Employees: 42
Company Website: https://www.polarityte.com/
Phone: 13852663151.0
The current stock price of PTE is 0.241 USD. The price decreased by -0.82% in the last trading session.
The exchange symbol of POLARITYTE INC is PTE and it is listed on the Nasdaq exchange.
PTE stock is listed on the Nasdaq exchange.
5 analysts have analysed PTE and the average price target is 0.82 USD. This implies a price increase of 238.59% is expected in the next year compared to the current price of 0.241. Check the POLARITYTE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
POLARITYTE INC (PTE) has a market capitalization of 1.78M USD. This makes PTE a Nano Cap stock.
POLARITYTE INC (PTE) currently has 42 employees.
POLARITYTE INC (PTE) has a resistance level at 0.4. Check the full technical report for a detailed analysis of PTE support and resistance levels.
The Revenue of POLARITYTE INC (PTE) is expected to decline by -100% in the next year. Check the estimates tab for more information on the PTE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PTE does not pay a dividend.
POLARITYTE INC (PTE) will report earnings on 2023-08-09.
POLARITYTE INC (PTE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.41).
ChartMill assigns a fundamental rating of 3 / 10 to PTE. PTE has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months PTE reported a non-GAAP Earnings per Share(EPS) of -2.41. The EPS increased by 61.44% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 80% to PTE. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 48.01% and a revenue growth -100% for PTE